[{"type": "title", "data": "OB NIFEdipine Protocol Preterm Tocolysis"}, {"type": "category", "data": "Patient Care"}, {"type": "note", "data": "<P>Women will be assessed for contraindications to tocolysis therapy including:- Any contraindication to continuing the pregnancy- Gestational age less than 24-0/7 weeks- Preeclampsia or other medical indication for delivery- Mature fetus- Chorioamnionitis- Imminent delivery- Intrauterine fetal death or lethal fetal abnormality- Abnormal fetal surveillance- Significant antepartum hemorrhage- Allergy to NIFEdipine- Maternal coronary artery disease or previous myocardial infarction- Maternal liver disease where metabolic function impaired</P><P>Use with caution- With concurrent administration of magnesium sulphate (risk of interaction)- Use of indomethacin with pre-existing oligohydramnios. Consult OB</P>"}, {"type": "order", "data": "Vital Signs (VS)", "value": "checked"}, {"type": "sentence", "data": "T;N, Once, Baseline"}, {"type": "order", "data": "Vital Signs (VS)", "value": "checked"}, {"type": "sentence", "data": "T;N, As per protocol, Monitoring following NIFEdipine Loading Dose"}, {"type": "order", "data": "Vital Signs (VS)", "value": "checked"}, {"type": "sentence", "data": "T;N, As per protocol, Monitoring relative to each maintenance dose"}, {"type": "order", "data": "Fetal Heart Monitoring External", "value": "checked"}, {"type": "sentence", "data": "T;N, As per protocol, See order comments"}, {"type": "order", "data": "Notify Provider", "value": "checked"}, {"type": "sentence", "data": "T;N, If Systolic Blood Pressure (SBP) less than or equal to 100 mmHg during NIFEdipine loading or maintenance dosing"}, {"type": "category", "data": "Activity"}, {"type": "order", "data": "Bedrest (BR)", "value": "checked"}, {"type": "sentence", "data": "T;N, Constant Order, With bathroom privileges"}, {"type": "category", "data": "Diet/Nutrition"}, {"type": "order", "data": "Regular Diet", "value": ""}, {"type": "sentence", "data": "T;N"}, {"type": "sentence", "data": "T;N, No solid foods until after contractions stop (loading dose of NIFEdipine complete)"}, {"type": "order", "data": "Maternity Diet", "value": ""}, {"type": "sentence", "data": "T;N"}, {"type": "sentence", "data": "T;N, No solid foods until after contractions stop (loading dose of NIFEdipine complete)"}, {"type": "order", "data": "Increase Oral Fluid Intake", "value": ""}, {"type": "sentence", "data": "T;N, Hydrate with clear fluids during loading dose of NIFEdipine time period"}, {"type": "category", "data": "Continuous Infusions"}, {"type": "order", "data": "Sodium Chloride 0.9% intravenous solution", "value": "checked"}, {"type": "sentence", "data": "1,000, IV, T;N, 125 mL/hr, 1,000"}, {"type": "note", "data": "If dehydrated and/or ketones in urine"}, {"type": "note", "data": "Placeholder for bolus IV fluids"}, {"type": "category", "data": "Medications"}, {"type": "note", "data": "Tocolysis"}, {"type": "note", "data": "NIFEdipine indicated as first line of treatment for preterm labour 32-0/7 to 34-6/7 weeks gestation with contractions of at least 2 in 10 minutes. NIFEdipine protocol may be used if less than 32 weeks if woman is unable to have indomethacin as a tocolytic. NIFEdipine may also be used at greater than 34 weeks to facilitate transport to a higher level facility"}, {"type": "note", "data": "Loading dose of NIFEdipine "}, {"type": "order", "data": "NIFEdipine", "value": ""}, {"type": "sentence", "data": "10 mg, PO, Cap, q1hr"}, {"type": "note", "data": "Maintenance&nbsp;Dosing "}, {"type": "note", "data": "Maintenance therapy should start 6 hours following completion of loading dose then every 12 hours for 48 hours"}, {"type": "order", "data": "NIFEdipine extended release", "value": ""}, {"type": "sentence", "data": "30 mg, PO, SR Tab, q12hr, for 4 dose(s)"}, {"type": "note", "data": "Maintenance therapy should start 6 hours following completion of loading dose. Maintenance can be increased up to 20 mg orally q4hr at physicians discretion. "}, {"type": "order", "data": "NIFEdipine", "value": ""}, {"type": "sentence", "data": "10 mg, PO, Cap, q4hr"}, {"type": "note", "data": "Indomethacin is recommended for 24-0/7 to 30-6/7 weeks gestation "}, {"type": "order", "data": "indomethacin", "value": ""}, {"type": "sentence", "data": "100 mg, PR, Supp, Once, For transport"}, {"type": "order", "data": "indomethacin", "value": ""}, {"type": "sentence", "data": "25 mg, PO, Cap, q6hr, for 8 dose(s)"}, {"type": "sentence", "data": "50 mg, PO, Cap, q6hr, for 8 dose(s)"}, {"type": "note", "data": "Antenatal Corticosteroid Therapy (select one option)"}, {"type": "note", "data": "betamethasone is recommended for 24-0/7 to 34-6/7 weeks gestation when delivery is expected within 7 days"}, {"type": "order", "data": "betamethasone 6 mg/mL injectable suspension", "value": ""}, {"type": "sentence", "data": "12 mg, IM, Injection, q24hr(sched), 2 dose(s)"}, {"type": "note", "data": "dexamethasone is recommended for 24-0/7 to 34-6/7 weeks gestation when delivery is expected within 7 days."}, {"type": "order", "data": "dexamethasone", "value": ""}, {"type": "sentence", "data": "6 mg, IM, Injection, q12hr, for 4 dose(s)"}, {"type": "category", "data": "Laboratory"}, {"type": "order", "data": "CBC w/ Diff", "value": ""}, {"type": "sentence", "data": "Blood, Routine collect, T;N, Once"}, {"type": "note", "data": "Select History Check, ABO/D Typing and Antibody Screen for Group and Screen "}, {"type": "order", "data": "History Check", "value": ""}, {"type": "sentence", "data": "Blood, Routine collect, T;N, Once"}, {"type": "order", "data": "ABO/D Typing", "value": ""}, {"type": "sentence", "data": "Blood, Routine collect, T;N, Once"}, {"type": "order", "data": "Antibody Screen", "value": ""}, {"type": "sentence", "data": "Blood, Routine collect, T;N, Once"}, {"type": "order", "data": "Urinalysis and Microscopic", "value": ""}, {"type": "sentence", "data": "Urine, Routine collect, T;N, Nurse collect"}, {"type": "order", "data": "Urine Culture", "value": ""}, {"type": "sentence", "data": "Midstream Urine, Routine collect, T;N, Nurse collect"}, {"type": "order", "data": "Fetal Fibronectin", "value": ""}, {"type": "sentence", "data": "Amniotic Fluid, ASAP collect, T;N, Once"}, {"type": "order", "data": "GBS Culture", "value": ""}, {"type": "sentence", "data": "Vag/Rectal, Routine collect, T;N, Nurse collect"}, {"type": "order", "data": "Chlamydia trachomatis and Neisseria gonorrhoeae DNA Cervix Nucleic Acid Amplification", "value": ""}, {"type": "sentence", "data": "Cervical, Routine collect, T;N, Nurse collect"}, {"type": "order", "data": "Chlamydia trachomatis and Neisseria gonorrhoeae DNA Urine Nucleic Acid Amplification", "value": ""}, {"type": "sentence", "data": "Initial Urine, Routine collect, T;N, Nurse collect"}, {"type": "order", "data": "Trichomonas NAAT Cervix", "value": ""}, {"type": "sentence", "data": "Cervical, Routine collect, T;N, Nurse collect"}, {"type": "order", "data": "Trichomonas NAAT Urine", "value": ""}, {"type": "sentence", "data": "Initial Urine, Routine collect, T;N, Nurse collect"}, {"type": "order", "data": "Bacterial Vaginosis Score Vaginal", "value": ""}, {"type": "sentence", "data": "Vaginal, Routine collect, T;N, Nurse collect"}]
